Mackenzie Financial Corp Exact Sciences Corp Transaction History
Mackenzie Financial Corp
- $65.9 Billion
- Q1 2025
A detailed history of Mackenzie Financial Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,281,639 shares of EXAS stock, worth $154 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,281,639
Previous 2,919,325
12.41%
Holding current value
$154 Million
Previous $164 Million
13.4%
% of portfolio
0.22%
Previous 0.24%
Shares
26 transactions
Others Institutions Holding EXAS
# of Institutions
642Shares Held
156MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$837 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$827 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$586 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$566 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$310 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...